Page 6 - Demo

61 About Bioteque1.1 Company OverviewBioteque Corporation (hereinafter referred to as Bioteque) was established in 1991. It is a domestic manufacturer of blood dialysisrelated consumables and the first company in Taiwan to obtain CE MARK, GMP, and FDA 510(k) international certifications and pass FDA factory inspections. Bioteque was approved for listing on the over-the-counter market in 2001. The company is currently registered as a medical consumables manufacturer, with its headquarters located in Taipei. Bioteque and its affiliates employ over 1,000 staff and operate two manufacturing plants in Taiwan and the Philippines, covering an area of 100,000 square meters. Both plants are equipped with advanced machinery and have passed ISO 13485 certification, meeting FDA, GMP, and quality system regulations. Bioteque's product range includes interventional radiology catheters (such as TPU pig-tail catheters and double J drainage catheters), vascular imaging catheters, blood circuit tubes, puncture needles, pharmaceutical soft bags, infusion sets, surgical drainage tubes, precision cylinders, and various critical medical components. Notably, the \circuit tube\holds the top market share in Taiwan, the pharmaceutical soft bags are among the top three global suppliers, and some of the internal catheters have over 30% market share in European countries. To pursue better development and sustainable operation, Biotequestarted construction of the Yilan Science Park flagship plant in December 2020. This capacity expansion will provide comprehensive Contract Development and Manufacturing Organization (CDMO) capabilities for partner collaborations. Bontech is committed to developing innovative products and offering holistic solutions to all customers. The quality assurance system is certified to ISO 13485 and QMS (GMP) standards and products are CE marked. In addition to existing product lines, Bioteque is currently undertaking several projects to develop new products, including advanced silicone and TPU catheters for long-term implantation. The company holds over 21 patents covering all areas of the medical field. At the same time, Bontech seeks to establish potential long-term partnerships with renowned and established national research institutions to develop innovative medical products. The company is actively engaged in various new product research programs and building long-term collaborative relationships with research institutions and manufacturing partners.About Industry andValue Chain Sustainable ManagementCorporate GovernanceEnvironmental SustainabilityEmployee CareSocial Co-prosperityAppendixBBIOTEQUE CORPORATION 2023 Sustainability Report